Adaptive Biotechnologies Corporation announced the appointment of Tycho Peterson as chief financial officer (CFO). Mr. Peterson brings several decades of financial leadership and experience within the life science and diagnostic industries. Mr. Peterson most recently held a 23-year tenure with J.P. Morgan Chase & Co., where he served as managing director, life science tools and diagnostics in the health care group.

Mr. Peterson joins Adaptive as the company undergoes a reorganization into two newly created business areas – Minimal Residual Disease (MRD) and Immune Medicine.